Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases

痴呆 疾病 医学 阿尔茨海默病 重症监护医学 认知功能衰退 病理
作者
Mohammed Dheyaa Marsool Marsool,Priyadarshi Prajjwal,Yeruva Bheemeswara Reddy,Ali Dheyaa Marsool Marsool,Justin Riley Lam,Varsha Nandwana
出处
期刊:Dm Disease-a-month [Elsevier BV]
卷期号:69 (5): 101547-101547 被引量:6
标识
DOI:10.1016/j.disamonth.2023.101547
摘要

Alzheimer's disease (AD) is a common neurological condition characterized by a gradual and progressive decline in memory, language, emotion, and cognition. It mainly affects elderly people. Due to the effects of AD, pharmaceutical medications and anticholinesterases have been vigorously promoted and approved by the FDA as a form of AD therapy. However, it was progressively found that these drugs did not address the underlying causes of AD pathogenesis; rather, they focused on the symptoms in order to enhance patients' cognitive outcomes. Consequently, a hunt for superior disease-modifying options is launched. Designing new therapeutic agents requires a thorough understanding of the neuroprotective processes and varied functions carried out by certain genes, and antibodies. In this comprehensive review article, we give an overview of the history of Alzheimer's disease, the significance of the blood-brain barrier in determining the scope of treatment options, as well as the advantages and disadvantages of the current therapeutic treatment options for stem cell therapy, immunotherapy, regenerative therapy, and improved Alzheimer's disease care and diagnosis. We have also included a discussion on the potential role of aducanumab and Lecanemab as a cutting-edge therapy in refractory Alzheimer's disease patients. Lecanemab has been recently approved by the FDA for the treatment of Alzheimer's disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SYLH应助科研通管家采纳,获得30
刚刚
科研通AI2S应助科研通管家采纳,获得10
刚刚
JJ发布了新的文献求助10
1秒前
Nugget发布了新的文献求助10
1秒前
邓紫依发布了新的文献求助10
1秒前
2秒前
2秒前
直率的问筠完成签到,获得积分10
3秒前
不发SCI不改名完成签到,获得积分10
3秒前
4秒前
5秒前
柯睿渊完成签到,获得积分10
5秒前
独特乘云完成签到,获得积分10
5秒前
贾克斯发布了新的文献求助10
5秒前
tlh完成签到 ,获得积分10
6秒前
陈彦滨完成签到 ,获得积分10
6秒前
7秒前
9秒前
9秒前
css完成签到,获得积分10
9秒前
Liufgui应助Re采纳,获得20
9秒前
Nugget完成签到,获得积分10
9秒前
yar应助潇湘雪月采纳,获得10
10秒前
宇宇发布了新的文献求助10
10秒前
shufessm完成签到,获得积分0
12秒前
12秒前
16秒前
幸福大白发布了新的文献求助30
16秒前
17秒前
肿瘤柳叶刀完成签到,获得积分10
18秒前
19秒前
19秒前
xxddw发布了新的文献求助10
20秒前
22秒前
GS11完成签到,获得积分10
23秒前
邓紫依完成签到,获得积分10
24秒前
cdytjt发布了新的文献求助60
24秒前
ai zs发布了新的文献求助10
24秒前
搜集达人应助zyw采纳,获得10
25秒前
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989406
求助须知:如何正确求助?哪些是违规求助? 3531522
关于积分的说明 11254187
捐赠科研通 3270174
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174